Revvity Inc
RVTY96.200USD
-0.060-0.06%
Fechamento 12/19, 16:00（ET）Cotações atrasadas em 15 min
10.97BValor de mercado
48.35P/L TTM
Mais detalhes de Revvity Inc Empresa
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Informações de Revvity Inc
Código da empresaRVTY
Nome da EmpresaRevvity Inc
Data de listagemAug 12, 2101
CEOSingh (Prahlad R)
Número de funcionários11000
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 12
Endereço77 4Th Avenue
CidadeWALTHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02451
Telefone17816636900
Sitehttps://www.revvity.com/
Código da empresaRVTY
Data de listagemAug 12, 2101
CEOSingh (Prahlad R)
Executivos da empresa Revvity Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+21.36%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
10.44K
-53.85%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+90.13%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+90.13%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Product
610.70M
84.79%
Service
109.58M
15.21%
Por RegiãoUSD
Nome
Receita
Proporção
Americas
323.58M
44.92%
Europe
203.63M
28.27%
Asia
193.07M
26.80%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Product
610.70M
84.79%
Service
109.58M
15.21%
Distribuição de ações
Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Outro
46.93%
Investidores
Investidores
Proporção
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Outro
46.93%
Tipos de investidores
Investidores
Proporção
Investment Advisor
70.04%
Investment Advisor/Hedge Fund
25.98%
Hedge Fund
2.79%
Pension Fund
1.77%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
1.07%
Individual Investor
0.30%
Family Office
0.05%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
T. Rowe Price Investment Management, Inc.
22.64M
19.51%
+126.19K
+0.56%
Jun 30, 2025
The Vanguard Group, Inc.
14.03M
12.09%
-297.65K
-2.08%
Jun 30, 2025
EdgePoint Investment Group Inc.
6.79M
5.85%
+1.43M
+26.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.80M
6.72%
-1.59M
-16.90%
Jun 30, 2025
Janus Henderson Investors
7.22M
6.22%
+1.23M
+20.47%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.81M
5%
-259.62K
-4.28%
Jun 30, 2025
State Street Investment Management (US)
5.02M
4.32%
-150.58K
-2.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.98M
2.56%
-18.52K
-0.62%
Jun 30, 2025
Invesco Capital Management LLC
1.94M
1.67%
+422.41K
+27.88%
Jun 30, 2025
UBS Financial Services, Inc.
1.75M
1.51%
+1.12M
+178.25%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
Ver Mais
First Trust Indxx Medical Devices ETF
Proporção2.12%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.85%
T Rowe Price Capital Appreciation Equity ETF
Proporção1.36%
Simplify Health Care ETF
Proporção1.29%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.16%
First Trust Health Care Alphadex Fund
Proporção0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proporção0.84%
VanEck Morningstar SMID Moat ETF
Proporção0.64%
Neuberger Berman Small-Mid Cap ETF
Proporção0.56%
NYLI Candriam US Mid Cap Equity ETF
Proporção0.5%
Dividendo
Um total de
168.35M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de Revvity Inc?
Os cinco principais acionistas de Revvity Inc são:
T. Rowe Price Investment Management, Inc. detém 22.64M Ações, representando 19.51% do total de Ações.
The Vanguard Group, Inc. detém 14.03M Ações, representando 12.09% do total de Ações.
EdgePoint Investment Group Inc. detém 6.79M Ações, representando 5.85% do total de Ações.
T. Rowe Price Associates, Inc. detém 7.80M Ações, representando 6.72% do total de Ações.
Janus Henderson Investors detém 7.22M Ações, representando 6.22% do total de Ações.
T. Rowe Price Investment Management, Inc. detém 22.64M Ações, representando 19.51% do total de Ações.
The Vanguard Group, Inc. detém 14.03M Ações, representando 12.09% do total de Ações.
EdgePoint Investment Group Inc. detém 6.79M Ações, representando 5.85% do total de Ações.
T. Rowe Price Associates, Inc. detém 7.80M Ações, representando 6.72% do total de Ações.
Janus Henderson Investors detém 7.22M Ações, representando 6.22% do total de Ações.
Quais são os três principais tipos de acionistas de Revvity Inc?
Os três principais tipos de acionistas da Revvity Inc são:
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
Quantas instituições possuem ações da Revvity Inc (RVTY)?
Em 2025Q3, 1177 instituições possuíam ações da Revvity Inc, com valor de mercado aproximado de 117.06M, representando 100.85% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em 2.82%.
Qual é a maior fonte de receita da Revvity Inc?
Em FY2025Q2, o segmento de negócios Product gerou a maior receita para Revvity Inc, totalizando 610.70M e representando 84.79% da receita total.
